Senomys(SNMX)- A Taste for Success!!! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Senomys(SNMX)- A Taste for Success!!!

SNMX 1.490

0.0%

Nov 5 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: im a survivor who wrote (71)	5/3/2005 3:36:25 PM
From: gfp927z	Read Replies (3) of 192

It's interesting to compare the relative clinical timetables for SNMX vrs a regular bio/pharma company. A regular bio company would have to have a drug well into its 2nd Phase 3 trial in order to realistically be able to produce sales/revenues by 2007 (considering the typical 1 year slow poke approval time for the FDA), and that assumes no approval glitches. And the bio company faces a high probability of non-approval for any number of reasons (efficacy, safety, FDA bias, etc). One of the big attractions of the Senomyx story is the comparative simplicity, speed, and high probability success of the regulatory process (FEMA/GRAS). Another big advantage is that while SNMX's taste modulating/enhancing technology is novel and very clever, they're not attempting to cure cancer, do gene therapy, or some other absurdly difficult and exotic science. Exotic science may be fun to follow, but as an investment it's a complete minefield -- a ridiculously expensive and lengthy process (hundreds of millions / 8-10 years), and one with a very low chance of success. In comparison, Senomyx's approach has a lot of appeal.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next